Renxian Tang

18PUBLICATIONS
28CO-AUTHORS
Haematological tumoursHost-parasite interactionsPredictive and prognostic markersBiomedical imagingMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 20, 2026
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.

|May 14, 2025
HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

Fanyun Kong, Ensi Bao, Yujie Zhong

|Oct 28, 2024
Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans.

Hongbo Guo, Jiaqi Xu, Jianwen Situ

|Apr 08, 2024
Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis.

Hong-Juan You, Qi Li, Li-Hong Ma

|Nov 29, 2023
miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15.

Jikai Zhang, Chunyang Li, Yao Hou

|Nov 15, 2023
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.

Dongchen Yuan, Jing Hu, Xiaoman Ju

Pageof 3

Frequent Collaborators

3 joint publications

Fanyun Kong

3 joint publications

Kuiyang Zheng

2 joint publications

Chen Li

2 joint publications

Wenshi Wang